No Data
No Data
Express News | Celularity Receives Nasdaq Notice Regarding Non-Payment of Nasdaq Fees
Celularity Says Welcomes Action By CMS to Revise To Jan. 1, 2026 The Effective Date Of Medicare Local Coverage Determination Titled 'Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers'
Celularity Announces Publication of "Senescence, NK Cells, and Cancer: Navigating the Crossroads of Aging and Disease" in the April 4, 2025, Issue of Frontiers in Immunology
Celularity Delays Yearly Report Filing Amid Financial Challenges
Express News | Celularity: Sees Net Revenues for Year Ended Dec 31, 2024 of $54.2 Mln
Express News | Celularity Files for Non-Timley 10-K - SEC Filing